Clinical Trial Update: REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating gender response to PDE5 inhibitors in diabetic cardiomyopathy and type 2 diabetes patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Cardiomyopathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Diabetic Cardiomyopathy, Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED